Trademarkia Logo

Canada

C$
LLY
REGISTERED

on 3 Feb 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndiana, IN 46285

US

Serial Number

1917627 filed on 30th Aug 2018

Registration Number

TMA1071581 registered on 3rd Feb 2020

Registration expiry Date

3rd Feb 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

LLY

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune disea Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain


Classification kind code

11

Mark Details


Serial Number

1917627

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 4th Sept 2019
Registration Pending
Submitted for opposition 191
on 4th Sept 2019
Registration Fee Notice Sent
Submitted for opposition 42
on 12th Jun 2019
Advertised
Submitted for opposition 26
on 23rd May 2019
Approved
Submitted for opposition 27
on 5th Apr 2019
Approval Notice Sent
Submitted for opposition 22
on 9th Jan 2019
Search Recorded
Submitted for opposition 20
on 9th Jan 2019
Examiner's First Report
Submitted for opposition 31
on 4th Sept 2018
Formalized
Submitted for opposition 1
on 31st Aug 2018
Created
Submitted for opposition 30
on 30th Aug 2018
Filed